report-image

Global Blood Glucose Monitoring System Market Analysis By Segmentations, Top Key Players, Geographical Expansion, Future Development & Forecast 2024-2035

  • PUBLISHED ON
  • 1/12/2023
  • NO OF PAGES
  • 242
  • CATEGORY
  • Healthcare & Life Sciences

In 2021, the market for Blood Glucose Monitoring System worldwide was worth $13 billion US dollars. AMR Group projects that the market will reach US$ 23.45 billion by 2031, growing at a CAGR of 9 percent between 2022 and 2031.

Industry Overview

A blood glucose monitoring system is a medical device that is used to measure the concentration of glucose (sugar) in a person's blood. It is primarily used by people with diabetes to monitor their blood glucose levels and adjust their medication, diet, and physical activity accordingly to manage their condition. A blood glucose monitoring system usually consists of a glucose meter and test strips. The user pricks their finger with a lancet to obtain a small drop of blood, which is placed on the test strip. The strip is then inserted into the meter, which reads the glucose concentration in the blood sample and displays the result on a screen. Blood glucose monitoring systems can be used at home or in a healthcare setting. Some blood glucose monitoring systems are also equipped with additional features, such as the ability to store and track glucose readings over time, and to communicate the data to healthcare professionals remotely.

Market Dynamics

The blood glucose monitoring system market is driven by several key dynamics: The growing prevalence of diabetes is one of the major factors driving the demand for blood glucose monitoring systems. According to the International Diabetes Federation, the number of adults with diabetes is expected to rise from 463 million in 2019 to 700 million by 2045. Increased awareness about diabetes and the importance of regular blood glucose monitoring is driving demand for blood glucose monitoring systems. Governments and healthcare organizations are also promoting diabetes screening programs, which is expected to increase demand for blood glucose monitoring systems.

Advancements in technology have led to the development of more accurate and user-friendly blood glucose monitoring systems. Continuous glucose monitoring (CGM) systems, for example, are becoming increasingly popular as they provide real-time glucose readings and can alert the user when glucose levels are too high or too low. The growing geriatric population is expected to drive demand for blood glucose monitoring systems as older adults are at higher risk of developing diabetes and require more frequent monitoring of their blood glucose levels. Reimbursement policies by governments and insurance companies can also impact the demand for blood glucose monitoring systems. Increased reimbursement rates can make these devices more affordable for patients and encourage wider adoption.

COVID Impact

The COVID-19 pandemic has had an impact on the blood glucose monitoring system market in several ways: The pandemic has resulted in the postponement of routine medical appointments, including diabetes check-ups. This has led to delayed diagnosis and treatment of diabetes, which has impacted the demand for blood glucose monitoring systems. Disrupted supply chains: The pandemic has disrupted global supply chains, which has led to shortages of blood glucose monitoring systems and related consumables such as test strips and lancets. This has impacted the availability of these products and increased their prices. Increased adoption of telemedicine: The pandemic has accelerated the adoption of telemedicine, which allows patients to consult with healthcare professionals remotely. This has led to increased demand for blood glucose monitoring systems that can be integrated with telemedicine platforms and enable remote monitoring of patients. Shift towards self-monitoring: The pandemic has led to a shift towards self-monitoring of blood glucose levels, as patients are avoiding hospitals and clinics due to the risk of infection. This has led to increased demand for blood glucose monitoring systems that are easy to use and can be used at home. Increased demand for continuous glucose monitoring (CGM): The pandemic has led to increased demand for CGM systems, which provide real-time glucose readings and enable remote monitoring of patients. This is particularly relevant for patients who are unable or reluctant to visit healthcare facilities due to the pandemic. Overall, while the COVID-19 pandemic has had some negative impacts on the blood glucose monitoring system market, it has also accelerated certain trends such as the adoption of telemedicine and self-monitoring, which are expected to drive long-term growth in the market.

Regional Trend

The blood glucose monitoring system market can be analyzed on a regional basis as follows:

North America: North America is a major market for blood glucose monitoring systems, with the US being the largest contributor to the market. The presence of a large diabetic population, high healthcare expenditure, and favorable reimbursement policies are some of the key factors driving the growth of the market in this region.

Europe: Europe is another significant market for blood glucose monitoring systems. The market is driven by factors such as the growing prevalence of diabetes, increasing awareness about the importance of regular blood glucose monitoring, and favorable reimbursement policies. Germany, France, and the UK are the largest markets in the region.

Asia Pacific: The Asia Pacific region is expected to witness significant growth in the blood glucose monitoring system market in the coming years. The growing prevalence of diabetes, increasing awareness about the importance of regular blood glucose monitoring, and rising healthcare expenditure are some of the key factors driving the growth of the market in this region. China, India, and Japan are the largest markets in the region.

Latin America: The Latin America blood glucose monitoring system market is expected to grow at a moderate pace due to the increasing prevalence of diabetes, improving healthcare infrastructure, and favorable government policies. Brazil and Mexico are the largest markets in the region.

Middle East and Africa: The blood glucose monitoring system market in the Middle East and Africa is relatively small but is expected to grow in the coming years due to the increasing prevalence of diabetes, improving healthcare infrastructure, and rising healthcare expenditure. South Africa, Saudi Arabia, and UAE are the largest markets in the region. Overall, the blood glucose monitoring system market is expected to witness significant growth in all regions due to the increasing prevalence of diabetes and growing awareness about the importance of regular blood glucose monitoring. However, the growth rates and market sizes may vary by region due to factors such as healthcare infrastructure, government policies, and reimbursement policies.

Competitive Landscape

The blood glucose monitoring system market is highly competitive, with several major players operating in the market. Some of the key players in the market include:

Abbott Laboratories: Abbott Laboratories is a leading player in the blood glucose monitoring system market, offering a wide range of products, including its flagship FreeStyle Libre system. The company also offers a range of blood glucose monitoring systems for hospital and laboratory settings.

Roche Diagnostics: Roche Diagnostics is another major player in the blood glucose monitoring system market, offering a range of products under its Accu-Chek brand. The company offers both self-monitoring blood glucose systems as well as continuous glucose monitoring systems.

Dexcom: Dexcom is a leading player in the continuous glucose monitoring system market, offering a range of products that enable real-time glucose monitoring. The company's products are widely used in hospital settings as well as for home monitoring.

Medtronic: Medtronic is a leading player in the insulin pump market and also offers a range of blood glucose monitoring systems. The company's products include continuous glucose monitoring systems as well as self-monitoring blood glucose systems.

Ascensia Diabetes Care: Ascensia Diabetes Care is a leading player in the self-monitoring blood glucose system market, offering a range of products under its Contour brand. The company's products are widely used in home monitoring as well as in hospital and laboratory settings. Other notable players in the market include Becton, Dickinson and Company, Terumo Corporation, Ypsomed AG, and Nipro Diagnostics. The market is characterized by intense competition, with players focusing on product innovation, pricing strategies, and marketing efforts to gain market share.

Market Segmentation

Market segmentation is the process of dividing a market into smaller groups of consumers with similar needs or characteristics. In the case of blood glucose monitoring systems, there are several ways in which the market can be segmented:

Demographic segmentation: This involves dividing the market based on demographic factors such as age, gender, income, education, and occupation. For example, blood glucose monitoring systems may be marketed differently to seniors compared to younger adults, or to people with diabetes who have a higher income level.

Geographic segmentation: This involves dividing the market based on geographic factors such as region, city, or climate. For example, blood glucose monitoring systems may be marketed differently in regions with a higher prevalence of diabetes, such as certain areas of the United States or Asia.

Behavioral segmentation: This involves dividing the market based on consumer behavior such as their attitudes, preferences, and buying habits. For example, blood glucose monitoring systems may be marketed differently to consumers who are proactive about managing their diabetes compared to those who are less engaged.

Psychographic segmentation: This involves dividing the market based on consumer lifestyles, values, and personality traits. For example, blood glucose monitoring systems may be marketed differently to consumers who prioritize convenience and ease-of-use, compared to those who prioritize accuracy and precision. Ultimately, the choice of segmentation strategy will depend on the specific needs and characteristics of the target market. A combination of demographic, geographic, behavioral, and psychographic factors may be used to create a comprehensive segmentation approach that targets the right consumers with the right messaging and marketing strategies.


Key Benefits:
• The analysis provides an overview of the factors driving and limiting the growth of the market including trends, structure and others.
• Market estimation for type and geographic segments is derived from the current market scenario and expected market trends.
• Porter’s Five Force Model and SWOT analysis are used to study the global Blood Glucose Monitoring System market and would help stakeholders make strategic decisions.
• The analysis assists in understanding the strategies adopted by the companies for the growth of this market.
• In-depth analysis of the types of Blood Glucose Monitoring System would help in identifying future applications in this market.

Reasons to Purchase this Report:
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Objectives of the Study:
• To provide with an exhaustive analysis on the Blood Glucose Monitoring System Market by Product, By Application, By End User and by Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
Base Year: 2023
Historic Year: 2016-2022
Forecast: 2024-2035
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Blood Glucose Monitoring System Revenue
1.4 Market Analysis by Type
1.4.1 Global Blood Glucose Monitoring System Market Size Growth Rate by Type: 2023 VS 2032
1.4.2 Self-Monitoring
1.4.3 Continuous Glucose Monitoring Devices
1.5 Market by Application
1.5.1 Global Blood Glucose Monitoring System Market Share by Application: 2023-2032
1.5.2 Household
1.5.3 Hospital
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Blood Glucose Monitoring System Market
1.8.1 Global Blood Glucose Monitoring System Market Status and Outlook (2017-2032)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Blood Glucose Monitoring System Production Capacity Market Share by Manufacturers (2017-2022)
2.2 Global Blood Glucose Monitoring System Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Blood Glucose Monitoring System Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Blood Glucose Monitoring System Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Blood Glucose Monitoring System Sales Volume Market Share by Region (2017-2022)
3.2 Global Blood Glucose Monitoring System Sales Revenue Market Share by Region (2017-2022)
3.3 North America Blood Glucose Monitoring System Sales Volume
3.3.1 North America Blood Glucose Monitoring System Sales Volume Growth Rate (2017-2022)
3.3.2 North America Blood Glucose Monitoring System Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.4 East Asia Blood Glucose Monitoring System Sales Volume
3.4.1 East Asia Blood Glucose Monitoring System Sales Volume Growth Rate (2017-2022)
3.4.2 East Asia Blood Glucose Monitoring System Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.5 Europe Blood Glucose Monitoring System Sales Volume (2017-2022)
3.5.1 Europe Blood Glucose Monitoring System Sales Volume Growth Rate (2017-2022)
3.5.2 Europe Blood Glucose Monitoring System Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.6 South Asia Blood Glucose Monitoring System Sales Volume (2017-2022)
3.6.1 South Asia Blood Glucose Monitoring System Sales Volume Growth Rate (2017-2022)
3.6.2 South Asia Blood Glucose Monitoring System Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.7 Southeast Asia Blood Glucose Monitoring System Sales Volume (2017-2022)
3.7.1 Southeast Asia Blood Glucose Monitoring System Sales Volume Growth Rate (2017-2022)
3.7.2 Southeast Asia Blood Glucose Monitoring System Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.8 Middle East Blood Glucose Monitoring System Sales Volume (2017-2022)
3.8.1 Middle East Blood Glucose Monitoring System Sales Volume Growth Rate (2017-2022)
3.8.2 Middle East Blood Glucose Monitoring System Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.9 Africa Blood Glucose Monitoring System Sales Volume (2017-2022)
3.9.1 Africa Blood Glucose Monitoring System Sales Volume Growth Rate (2017-2022)
3.9.2 Africa Blood Glucose Monitoring System Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.10 Oceania Blood Glucose Monitoring System Sales Volume (2017-2022)
3.10.1 Oceania Blood Glucose Monitoring System Sales Volume Growth Rate (2017-2022)
3.10.2 Oceania Blood Glucose Monitoring System Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.11 South America Blood Glucose Monitoring System Sales Volume (2017-2022)
3.11.1 South America Blood Glucose Monitoring System Sales Volume Growth Rate (2017-2022)
3.11.2 South America Blood Glucose Monitoring System Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
3.12 Rest of the World Blood Glucose Monitoring System Sales Volume (2017-2022)
3.12.1 Rest of the World Blood Glucose Monitoring System Sales Volume Growth Rate (2017-2022)
3.12.2 Rest of the World Blood Glucose Monitoring System Sales Volume Capacity, Revenue, Price and Gross Margin (2017-2022)
4 North America
4.1 North America Blood Glucose Monitoring System Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Blood Glucose Monitoring System Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Blood Glucose Monitoring System Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Blood Glucose Monitoring System Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Blood Glucose Monitoring System Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Blood Glucose Monitoring System Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Blood Glucose Monitoring System Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Blood Glucose Monitoring System Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Blood Glucose Monitoring System Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Blood Glucose Monitoring System Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Blood Glucose Monitoring System Sales Volume Market Share by Type (2017-2022)
14.2 Global Blood Glucose Monitoring System Sales Revenue Market Share by Type (2017-2022)
14.3 Global Blood Glucose Monitoring System Sales Price by Type (2017-2022)
15 Consumption Analysis by Application
15.1 Global Blood Glucose Monitoring System Consumption Volume by Application (2017-2022)
15.2 Global Blood Glucose Monitoring System Consumption Value by Application (2017-2022)
16 Company Profiles and Key Figures in Blood Glucose Monitoring System Business
16.1 Abbott Laboratories
16.1.1 Abbott Laboratories Company Profile
16.1.2 Abbott Laboratories Blood Glucose Monitoring System Product Specification
16.1.3 Abbott Laboratories Blood Glucose Monitoring System Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.2 F. Hoffmann-La Roche
16.2.1 F. Hoffmann-La Roche Company Profile
16.2.2 F. Hoffmann-La Roche Blood Glucose Monitoring System Product Specification
16.2.3 F. Hoffmann-La Roche Blood Glucose Monitoring System Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.3 Lifescan
16.3.1 Lifescan Company Profile
16.3.2 Lifescan Blood Glucose Monitoring System Product Specification
16.3.3 Lifescan Blood Glucose Monitoring System Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.4 Ascensia Diabetes Care
16.4.1 Ascensia Diabetes Care Company Profile
16.4.2 Ascensia Diabetes Care Blood Glucose Monitoring System Product Specification
16.4.3 Ascensia Diabetes Care Blood Glucose Monitoring System Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.5 Dexcom
16.5.1 Dexcom Company Profile
16.5.2 Dexcom Blood Glucose Monitoring System Product Specification
16.5.3 Dexcom Blood Glucose Monitoring System Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.6 Medtronic
16.6.1 Medtronic Company Profile
16.6.2 Medtronic Blood Glucose Monitoring System Product Specification
16.6.3 Medtronic Blood Glucose Monitoring System Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.7 Ypsomed
16.7.1 Ypsomed Company Profile
16.7.2 Ypsomed Blood Glucose Monitoring System Product Specification
16.7.3 Ypsomed Blood Glucose Monitoring System Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.8 B. Braun Melsungen
16.8.1 B. Braun Melsungen Company Profile
16.8.2 B. Braun Melsungen Blood Glucose Monitoring System Product Specification
16.8.3 B. Braun Melsungen Blood Glucose Monitoring System Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.9 Nipro
16.9.1 Nipro Company Profile
16.9.2 Nipro Blood Glucose Monitoring System Product Specification
16.9.3 Nipro Blood Glucose Monitoring System Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.10 Sanofi
16.10.1 Sanofi Company Profile
16.10.2 Sanofi Blood Glucose Monitoring System Product Specification
16.10.3 Sanofi Blood Glucose Monitoring System Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.11 Arkray
16.11.1 Arkray Company Profile
16.11.2 Arkray Blood Glucose Monitoring System Product Specification
16.11.3 Arkray Blood Glucose Monitoring System Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.12 Prodigy Diabetes Care
16.12.1 Prodigy Diabetes Care Company Profile
16.12.2 Prodigy Diabetes Care Blood Glucose Monitoring System Product Specification
16.12.3 Prodigy Diabetes Care Blood Glucose Monitoring System Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.13 Acon Laboratories
16.13.1 Acon Laboratories Company Profile
16.13.2 Acon Laboratories Blood Glucose Monitoring System Product Specification
16.13.3 Acon Laboratories Blood Glucose Monitoring System Production Capacity, Revenue, Price and Gross Margin (2017-2022)
16.14 Nova Biomedical
16.14.1 Nova Biomedical Company Profile
16.14.2 Nova Biomedical Blood Glucose Monitoring System Product Specification
16.14.3 Nova Biomedical Blood Glucose Monitoring System Production Capacity, Revenue, Price and Gross Margin (2017-2022)
17 Blood Glucose Monitoring System Manufacturing Cost Analysis
17.1 Blood Glucose Monitoring System Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Blood Glucose Monitoring System
17.4 Blood Glucose Monitoring System Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Blood Glucose Monitoring System Distributors List
18.3 Blood Glucose Monitoring System Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Blood Glucose Monitoring System (2023-2032)
20.2 Global Forecasted Revenue of Blood Glucose Monitoring System (2023-2032)
20.3 Global Forecasted Price of Blood Glucose Monitoring System (2017-2032)
20.4 Global Forecasted Production of Blood Glucose Monitoring System by Region (2023-2032)
20.4.1 North America Blood Glucose Monitoring System Production, Revenue Forecast (2023-2032)
20.4.2 East Asia Blood Glucose Monitoring System Production, Revenue Forecast (2023-2032)
20.4.3 Europe Blood Glucose Monitoring System Production, Revenue Forecast (2023-2032)
20.4.4 South Asia Blood Glucose Monitoring System Production, Revenue Forecast (2023-2032)
20.4.5 Southeast Asia Blood Glucose Monitoring System Production, Revenue Forecast (2023-2032)
20.4.6 Middle East Blood Glucose Monitoring System Production, Revenue Forecast (2023-2032)
20.4.7 Africa Blood Glucose Monitoring System Production, Revenue Forecast (2023-2032)
20.4.8 Oceania Blood Glucose Monitoring System Production, Revenue Forecast (2023-2032)
20.4.9 South America Blood Glucose Monitoring System Production, Revenue Forecast (2023-2032)
20.4.10 Rest of the World Blood Glucose Monitoring System Production, Revenue Forecast (2023-2032)
20.5 Forecast by Type and by Application (2023-2032)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2023-2032)
20.5.2 Global Forecasted Consumption of Blood Glucose Monitoring System by Application (2023-2032)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Blood Glucose Monitoring System by Country
21.2 East Asia Market Forecasted Consumption of Blood Glucose Monitoring System by Country
21.3 Europe Market Forecasted Consumption of Blood Glucose Monitoring System by Countriy
21.4 South Asia Forecasted Consumption of Blood Glucose Monitoring System by Country
21.5 Southeast Asia Forecasted Consumption of Blood Glucose Monitoring System by Country
21.6 Middle East Forecasted Consumption of Blood Glucose Monitoring System by Country
21.7 Africa Forecasted Consumption of Blood Glucose Monitoring System by Country
21.8 Oceania Forecasted Consumption of Blood Glucose Monitoring System by Country
21.9 South America Forecasted Consumption of Blood Glucose Monitoring System by Country
21.10 Rest of the world Forecasted Consumption of Blood Glucose Monitoring System by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer

Quality Assurance Process

  1. We Market Research’s Quality Assurance program strives to deliver superior value to our clients.

We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.

Market Research Process




We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.

To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
  • Project kickoff meeting with client
  • Conduct frequent client communications
  • Form project steering committee
  • Assign a senior SR executive as QA Executive
  • Conduct internal editorial & quality reviews of project deliverables
  • Certify project staff in SR methodologies & standards
  • Monitor client satisfaction
  • Monitor realized value post-project

Case Study- Automotive Sector

One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).

Solution

The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research

The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.

Market Estimates and Forecast

In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.

Case Study- ICT Sector

Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.


Business Solution

An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.


Conclusion

The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.


CHOOSE LICENSE TYPE
QLOUD
Pricing

Select a license type that suits your business needs

Single User Access

US $3950

Only Three Thousand Nine Hundred Fifty US dollar

  • 1 User access
  • 15% Additional Free Customization
  • Free Unlimited post-sale support
  • 100% Service Guarantee until achievement of ROI
Multi User Cost

US $4950

Only Four Thousand Nine Hundred Fifty US dollar

  • 5 Users access
  • 25% Additional Free Customization
  • Access Report summaries for Free
  • Guaranteed service
  • Dedicated Account Manager
  • Discount of 20% on next purchase
  • Get personalized market brief from Lead Author
  • Printing of Report permitted
  • Discount of 20% on next purchase
  • 100% Service Guarantee until achievement of ROI
Enterprise User Cost

US $5950

Only Five Thousand Nine Hundred Fifty US dollar

  • Unlimited User Access
  • 30% Additional Free Customization
  • Exclusive Previews to latest or upcoming reports
  • Discount of 30% on next purchase
  • 100% Service Guarantee until achievement of ROI